Intersect ENT Inc (XENT)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

1555 ADAMS DRIVE MENLO PARK, CA 94025

Intersect ENT is a global ear, nose and throat medical technology leader dedicated to transforming patient care. The Company's steroid releasing implants are designed to provide mechanical spacing and deliver targeted therapy to the site of disease. In addition, Intersect ENT is continuing to expand its portfolio of products based on the Company's unique localized steroid releasing technology and is committed to broadening patient access to less invasive and more cost-effective care. In October 2020, Intersect ENT acquired Fiagon AG Medical Technologies, a global leader in electromagnetic surgical navigation solutions with an expansive portfolio of ENT product offerings, including the VENSURE sinus balloon, that complement the Company's PROPEL® and SINUVA® sinus implants and extend its geographic reach.

Data as of 2021-09-19 12:54:33 -0400
Market Cap907.822 Million Shares Outstanding33.315 Million Avg 30-day Volume373.285 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE13.63 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.51175 52-week High/Low28.17 / 14.68 Next Earnings Date2021-11-01 Price to Cash FLow (P/CF) -34.1182
Data provided by IEX Cloud
View SEC Filings from XENT instead.

View recent insider trading info

Funds Holding XENT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding XENT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WEST THOMAS A. PRESIDENT AND CEO

257,294 2021-07-23 3

MEAD DANA G JR.

29,863 2021-06-03 1

GALLAHUE KIERAN

43,246 2021-06-03 2

LUCCHESE CYNTHIA L

25,356 2021-06-03 2

KLINE TERESA L.

17,810 2021-06-03 2

SANDOVAL ELISABETH

15,896 2021-04-05 2

HATTANGADI NEIL A

0 2021-03-10 2

KOWALSKI CHRISTINE R EVP & CHIEF OPERATING OFFICER

41,042 2021-02-04 2

MEIER RICHARD A EVP & CHIEF FINANCIAL OFFICER

135,533 2021-02-01 2

MOLL FREDERIC H

260,961 2021-01-19 1

CARSCADDEN GWEN R. CHIEF PEOPLE OFFICER

14,790 2021-01-04 1

BRODERICK PATRICK A EVP, GC & CORPORATE SECRETARY

24,156 2020-12-02 2

FERNANDEZ REYNA M CHIEF HUMAN RESOURCE OFFICER

16,104 2020-12-02 2

VERNON W ANTHONY

11,383 2020-06-04 0

BINNEY ROBERT H JR CHIEF COMMERCIAL OFFICER

37,555 2020-03-02 0

LEHMAN DAVID AARON EVP & GENERAL COUNSEL

79,205 2020-02-03 0

EARNHARDT LISA D

379,365 2019-07-24 0

STIMSON SUSAN P CHIEF STRATEGY OFFICER

35,982 2019-06-13 0

HILLEMAN JERYL L CHIEF FINANCIAL OFFICER

43,836 2019-05-07 0

KAUFMAN RICHARD E TECHNICAL ADVISOR

85,280 2019-01-01 0

PARKER DRAKE R. CHIEF BUSINESS OFFICER

3,000 2018-01-17 0

TANSEY CASEY M

2,546 2017-06-01 0

WOLBECK AMY V.P. REGULATORY AFFAIRS & QLTY

5,700 2016-09-06 0

STAMBAUGH JAMES VP CLINICAL AFFAIRS

20,000 2016-09-02 0

MCKHANN CHAS CHIEF COMMERCIAL OFFICER

0 2016-01-15 0

DE CLERCQ CASPER L.

  • Director
1,200,353 2015-05-12 0

KLEINER PERKINS CAUFIELD & BYERS XI-A LP

KLEINER PERKINS CAUFIELD & BYERS XI B LP

KPCB XI ASSOCIATES, LLC

  • 10% Owner
No longer subject to file 2015-05-11 0

PRESIDIO MANAGEMENT GROUP IX, L.L.C.

U S VENTURE PARTNERS IX L P

FEDERMAN IRWIN

KRAUSZ STEVEN M

LIDDLE DAVID E

MATTEUCCI PAUL A

ROOT JONATHAN D

YOUNG PHILIP M

  • 10% Owner
No longer subject to file 2015-05-08 0

PTV SCIENCES II L P

PINTO TECHNOLOGY VENTURES GP II, L.P.

PINTO TV GP CO LLC

CRAWFORD MATTHEW S

  • 10% Owner
No longer subject to file 2015-01-19 0

ANDERSON RICK D

  • 10% Owner
No longer subject to file 2015-01-19 0

NORWEST VENTURE PARTNERS XI, LP

NORWEST VENTURE PARTNERS XII, LP

HAQUE PROMOD

HOWARD MATTHEW D.

CROWE JEFFREY

  • 10% Owner
No longer subject to file 2014-07-29 0

PTV SCIENCES II L P

PINTO TECHNOLOGY VENTURES GP II, L.P.

PINTO TV GP CO LLC

  • 10% Owner
2,576,966 2014-07-29 0

FLETCHER MARK J

  • Director
1,198,296 2014-07-29 0

PTV SCIENCES II L P

PINTO TECHNOLOGY VENTURES GP II, L.P.

PINTO TV GP CO LLC

CRAWFORD MATTHEW S

ANDERSON RICK D

  • 10% Owner
0 2014-07-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
INTERSECT ENT INC XENT 2021-09-22 22:15:03 UTC -0.3598 0.4298 800000
INTERSECT ENT INC XENT 2021-09-22 21:45:03 UTC -0.3598 0.4298 800000
INTERSECT ENT INC XENT 2021-09-22 21:15:03 UTC -0.3598 0.4298 800000
INTERSECT ENT INC XENT 2021-09-22 20:45:02 UTC -0.3598 0.4298 800000
INTERSECT ENT INC XENT 2021-09-22 20:15:03 UTC -0.3598 0.4298 800000
INTERSECT ENT INC XENT 2021-09-22 19:45:03 UTC -0.3598 0.4298 800000
INTERSECT ENT INC XENT 2021-09-22 19:15:03 UTC -0.3598 0.4298 800000
INTERSECT ENT INC XENT 2021-09-22 18:45:03 UTC -0.3598 0.4298 800000
INTERSECT ENT INC XENT 2021-09-22 18:15:04 UTC -0.3598 0.4298 800000
INTERSECT ENT INC XENT 2021-09-22 17:45:04 UTC -0.3598 0.4298 800000
INTERSECT ENT INC XENT 2021-09-22 17:15:03 UTC -0.3598 0.4298 800000
INTERSECT ENT INC XENT 2021-09-22 16:45:03 UTC -0.2161 0.2861 800000
INTERSECT ENT INC XENT 2021-09-22 16:15:03 UTC -0.2161 0.2861 800000
INTERSECT ENT INC XENT 2021-09-22 15:45:03 UTC -0.2161 0.2861 800000
INTERSECT ENT INC XENT 2021-09-22 15:15:03 UTC -0.2161 0.2861 800000
INTERSECT ENT INC XENT 2021-09-22 14:45:03 UTC -0.2431 0.3131 800000
INTERSECT ENT INC XENT 2021-09-22 14:15:03 UTC -0.2431 0.3131 800000
INTERSECT ENT INC XENT 2021-09-22 13:45:04 UTC -0.2431 0.3131 800000
INTERSECT ENT INC XENT 2021-09-22 13:15:03 UTC -0.2431 0.3131 800000
INTERSECT ENT INC XENT 2021-09-22 12:45:03 UTC -0.2431 0.3131 800000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund XENT -262.0 shares, $-3104.7 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund XENT -26.0 shares, $-308.1 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund XENT -195.0 shares, $-2310.75 2020-03-31 N-PORT

Elevate your investments